Elezanumab
Elezanumab Uses, Dosage, Side Effects, Food Interaction and all others data.
Elezanumab is under investigation in clinical trial NCT03737812 (A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis).
| Trade Name | Elezanumab |
| Generic | Elezanumab |
| Elezanumab Other Names | Elezanumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Elezanumab
